Clinical Trials in Pittsburgh

Showing 16421-16440 of 21,047 trials

Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer

NCT01031381

This study will investigate the efficacy as well as the safety of RAD001 in combination with bevacizumab for recurrent ovarian, peritoneal, and fallopian tube cancer. RAD001 will be taken orally once daily and bevacizumab will be administered once every 14 days. The study will be conducted over a period of about 3 to 4 years.

Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma

University of Pittsburgh50 participantsStarted Sep 2010

Pittsburgh, Pennsylvania, United States

WITHDRAWNPhase 2< 1 mile

A Study of RO5036505 in Patients With Moderate to Severe Asthma

NCT00967590

This randomized, double-blind, placebo-controlled study will evaluate the efficacy, safety and tolerability of RO5036505 in patients with inadequately controlled moderate to severe asthma. Patients will be randomized to receive either RO5036505 (380mg iv infusion once weekly) or placebo for 8 weeks. Patients will be on a standardized inhaled corticosteroid/long-acting beta-agonist regimen during study treatment. Target sample size is 50-100 individuals.

Asthma

Hoffmann-La RocheStarted Sep 2009

Little Rock, Arkansas, United States • San Diego, California, United States • Denver, Colorado, United States +13 more locations

Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer

A Study of RO5036505 in Patients With Moderate to Severe Asthma

Find Trials by Condition in Pittsburgh

A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer

Reducing Sedentary Behavior vs. Increasing Physical Activity in Older Adults

Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials

Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis

Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma

A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza

Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control

Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema

A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer

Sensor Optimization of Cardiac Resynchronization Therapy Response

Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps

Hydros and Hydros-TA Joint Therapy for Pain Associated With Knee Osteoarthritis

A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)

Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects

Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer